Moderna, Inc.
NASDAQ:MRNA
39.77 (USD) • At close November 14, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||
| Current Assets: | ||||||||
| Cash & Cash Equivalents
| 2,907 | 3,205 | 6,848 | 2,624 | 235.876 | 658.364 | 134.859 | 50.08 |
| Short Term Investments
| 5,697 | 6,697 | 3,879 | 1,984 | 867.124 | 863.063 | 621.17 | 1,008.058 |
| Cash and Short Term Investments
| 8,604 | 9,902 | 10,727 | 4,608 | 1,103 | 1,521.427 | 756.029 | 1,058.138 |
| Net Receivables
| 892 | 1,385 | 3,175 | 1,408 | 5.369 | 30.583 | 18.404 | 17.951 |
| Inventory
| 202 | 949 | 1,441 | 47 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 643 | 1,364 | 607 | 252 | 20.435 | 10.996 | 8.79 | 11.063 |
| Total Current Assets
| 10,325 | 13,431 | 16,071 | 6,298 | 1,128.804 | 1,563.006 | 783.223 | 1,087.152 |
| Non-Current Assets: | ||||||||
| Property, Plant & Equipment, Net
| 2,658 | 2,139 | 1,383 | 387 | 287.909 | 211.977 | 139.031 | 81.207 |
| Goodwill
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 44 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 96 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 4,743 | 8,360 | 6,843 | 639 | 159.987 | 172.99 | 145.851 | 236.569 |
| Tax Assets
| 81 | 982 | 326 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 523 | 946 | 46 | 13 | 12.722 | 14.176 | 16.384 | 12.233 |
| Total Non-Current Assets
| 8,101 | 12,427 | 8,598 | 1,039 | 460.618 | 399.143 | 301.266 | 330.009 |
| Total Assets
| 18,426 | 25,858 | 24,669 | 7,337 | 1,589.422 | 1,962.149 | 1,084.489 | 1,417.161 |
| Liabilities & Equity: | ||||||||
| Current Liabilities: | ||||||||
| Account Payables
| 520 | 487 | 302 | 18 | 7.09 | 31.21 | 20.725 | 28.157 |
| Short Term Debt
| 88 | 244 | 1,087 | 30 | 0 | 0 | 0 | 0 |
| Tax Payables
| 63 | 48 | 876 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 568 | 2,038 | 6,253 | 3,867 | 63.31 | 109.056 | 96.739 | 107.739 |
| Other Current Liabilities
| 1,839 | 2,154 | 1,486 | 4,341 | 72.715 | 82.537 | 73.997 | 26.906 |
| Total Current Liabilities
| 3,015 | 4,923 | 9,128 | 4,389 | 143.115 | 222.803 | 191.461 | 162.802 |
| Non-Current Liabilities: | ||||||||
| Long Term Debt
| 1,218 | 1,004 | 705 | 207 | 132.364 | 33.489 | 15.687 | 12.5 |
| Deferred Revenue Non-Current
| 83 | 673 | 615 | 177 | 138.995 | 165.352 | 242.929 | 394.25 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 256 | 135 | 76 | 180 | 0.138 | 10.264 | 9.116 | 5.758 |
| Total Non-Current Liabilities
| 1,557 | 1,812 | 1,396 | 387 | 271.497 | 209.105 | 267.732 | 412.508 |
| Total Liabilities
| 4,572 | 6,735 | 10,524 | 4,776 | 414.612 | 431.908 | 459.193 | 575.31 |
| Equity: | ||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 1,176.661 | 1,176.661 |
| Common Stock
| 0 | 0 | 0 | 0 | 0.034 | 0.033 | 0.006 | 0.006 |
| Retained Earnings
| 13,606 | 18,320 | 9,958 | -2,244 | -1,496.454 | -1,006.627 | -621.893 | -365.718 |
| Accumulated Other Comprehensive Income/Loss
| -123 | -370 | -24 | 3 | 1.804 | -1.32 | -1.157 | -0.403 |
| Other Total Stockholders Equity
| 371 | 1,173 | 4,211 | 4,802 | 2,669.426 | 2,538.155 | 71.679 | 31.305 |
| Total Shareholders Equity
| 13,854 | 19,123 | 14,145 | 2,561 | 1,174.81 | 1,530.241 | 625.296 | 841.851 |
| Total Equity
| 13,854 | 19,123 | 14,145 | 2,561 | 1,174.81 | 1,530.241 | 625.296 | 841.851 |
| Total Liabilities & Shareholders Equity
| 18,426 | 25,858 | 24,669 | 7,337 | 1,589.422 | 1,962.149 | 1,084.489 | 1,417.161 |